Aeon Co., Ltd. reported Q1 2027 results on July 10, 2026, with sales of ¥2,702,257 million, revenue of ¥2,941,981 million, and net income of ¥13,809 million, marking a return to profitability versus a loss a year earlier.
The swing from a basic loss per share of ¥2.54 to earnings of ¥4.99 from continuing operations highlights a sharp improvement in Aeon’s underlying performance.
We’ll now examine how Aeon’s return to profitability and higher revenue in Q1 2027 may reshape its existing...
In recent weeks, Asian markets have experienced significant volatility, with technology stocks facing downward pressure amid concerns over valuations and geopolitical tensions. Despite these challenges, the region presents opportunities for investors seeking undervalued stocks that may offer potential value based on current market conditions. Identifying such stocks requires a careful analysis of financial health, growth prospects, and market positioning within the broader economic landscape.
Sotetsu Holdings (TSE:9003) has drawn fresh attention after setting the terms for its 47th unsecured bond issue, a ¥10.0b, 10 year offering carrying a 3.224% annual coupon and general public placement.
See our latest analysis for Sotetsu Holdings.
For context, Sotetsu Holdings’ share price has risen 8.07% over the past month but is down 9.37% over the past quarter, while its 1 year total shareholder return of 14.59% points to momentum building over a longer horizon.
If this bond issue has you...
Eisai and Biogen recently reported real-world data from the three-year LEADER study showing that nearly 83% of early Alzheimer’s patients on Leqembi remained stable or improved over about 17 months, and secured U.S. FDA approval for once-weekly subcutaneous Leqembi Iqlik as an at-home initiation option.
These updates suggest that Leqembi’s convenience, persistence on therapy and consistency across diverse patient groups could be increasingly important drivers of its clinical and commercial...
MediPal Holdings (TSE:7459) has updated investors with higher full year dividend guidance and revised earnings expectations after completing its tender offer for PALTAC Corporation, which shifts more of PALTAC's profit fully onto its books.
See our latest analysis for MediPal Holdings.
Recent moves suggest growing interest in MediPal Holdings, with a 1 month share price return of 9.92% and a 1 year total shareholder return of 19.90%. This points to building momentum around the revised...
Tsuruha Holdings Inc. previously reported first-quarter 2026 results, with sales rising to ¥636,886 million from ¥272,530 million and net income increasing to ¥13,477 million from ¥11,112 million a year earlier.
Despite higher sales and net income, basic earnings per share from continuing operations fell to ¥29.75 from ¥45.66, hinting at changes in share count or profit mix that matter for investors.
Next, we examine how this mix of rapid sales expansion and lower earnings per share shapes...
Europe’s record heat is turning air conditioning from a luxury into critical infrastructure, and that shift is starting to influence where capital flows. As governments debate funding for cooling in hospitals and schools and push for greener, more efficient systems, some stocks exposed to this climate adaptation story could see fresh attention while others may face tougher questions. This article explores how the news-driven theme around European air conditioning expansion connects to three...
COSMOS Pharmaceutical Corporation recently reported full-year results for the year ended May 31, 2026, with sales of ¥1,099,583 million, net income of ¥32,046 million, and basic earnings per share of ¥404.33, alongside an increased annual dividend of ¥44.50 per share for fiscal 2026.
At the same time, the company outlined lower year-end dividend guidance of ¥42.00 per share and issued detailed earnings forecasts for fiscal 2027, giving investors clearer visibility into expected sales,...
Tokyo Steel Manufacturing (TSE:5423) opened Q1 2027 with revenue of ¥72,927 million and basic EPS of ¥18.40, setting the tone for a period where trailing figures and recent quarters tell a mixed story on profitability. Over the last five reported quarters, revenue has moved between ¥60,032 million and ¥73,862 million while basic EPS has ranged from ¥8.19 to ¥47.11, giving investors a clear view of how earnings have tracked against a relatively tight revenue band. With trailing margins thinner...
Nuclear energy stocks are back in focus as investors look for power sources that are both reliable and less exposed to the swings in fossil fuel markets, especially with energy prices and inflation closely watched across regions. The Nuclear Energy Stocks screener helps you quickly filter companies involved in uranium production, enrichment and reactor operations so you can focus on businesses tied directly to long term electricity demand and energy security themes. In this article, you will...
Mitsui (TSE:8031) has partnered with PureCycle Technologies and RM TOHCELLO to introduce recycled polypropylene BOPP films in Japan.
The collaboration uses PureCycle's recycling process to supply high purity recycled resin for BOPP film production.
Pilot production has already produced usable results, with commercial agreements targeted by 2027.
Mitsui enters this agreement with recycled polypropylene BOPP films as a fresh area of focus, while its share price stands around ¥4,662.0. The...
Baycurrent (TSE:6532) opened Q1 2027 with revenue of ¥44,576 million and basic EPS of ¥70.99, while the trailing twelve months show revenue of ¥158.6 billion and basic EPS of ¥260.82, with earnings growth of 20.6% over the past year. The company has seen revenue move from ¥123,066 million in the trailing twelve months to Q1 2026 to ¥158,601 million in the latest period, as basic EPS over the same trailing window shifted from ¥215.80 to ¥260.82. This quarter serves as a checkpoint on whether...